B-cell-directed therapy for chronic graft-versus-host disease.
Jacobson
Caron A
CA
Ritz
Jerome
J
D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D053264:B-Cell Activating Factor / Q000097:blood; D001402:B-Lymphocytes / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000628:therapy; D002648:Child; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000097:blood / Q000628:therapy; D005260:Female; D006086:Graft vs Host Disease / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D019337:Hematologic Neoplasms / Q000097:blood / Q000628:therapy; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D000069283:Rituximab; D033581:Stem Cell Transplantation; D013256:Steroids / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014376:Tuberculosis / Q000097:blood / Q000628:therapy
D058846:Antibodies, Monoclonal, Murine-Derived; D053264:B-Cell Activating Factor; D007155:Immunologic Factors; D013256:Steroids; D000069283:Rituximab